Sylvia Bhatt

Sylvia Bhatt at University of Florida has focused on the cardiovascular and vascular toxicities of anti-VEGF therapies, which are increasingly used across many cancer types. Her research on hypertension management, thrombosis risk, wound healing complications, and proteinuria with VEGF/VEGFR inhibitors has contributed to practical oncology guidelines for safely managing patients on these agents.